Latest Technology And Innovation News

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

DUG Technology reports a landmark US$52 million services order book for FY25 despite a net loss, driven by new imaging tech and mobile data centre launches.

Objective Corporation reports robust FY2025 results with strong recurring revenue growth and deepening AI integration, setting ambitious targets for FY2026.

Insignia Financial delivered a robust FY25 performance with an 18% rise in underlying net profit after tax, driven by higher funds under management and cost efficiencies, while announcing a $3.3 billion acquisition agreement with CC Capital Partners.

Pharmx Technologies has reported a 13% revenue increase to $7.5 million for FY25, driven by expanded partnerships and platform innovations, despite a dip in EBITDA due to heavy investment.

HUB24 Limited has reported a standout FY25 with robust revenue growth, record net inflows, and a significant dividend increase, reinforcing its leadership in Australia's wealth management platform sector.

I Synergy Group Limited has formalised a A$300,000 contract with Treasure Global Inc. to supply AI-focused GPUs and specialised software, marking a strategic step in its technology evolution.

Insurance Australia Group Limited (IAG) reported a 51.3% rise in net profit after tax for FY25, supported by premium growth, improved margins, and key strategic alliances. The company also advanced its sustainability agenda with full renewable energy procurement and emissions reductions.

Lithium Universe Limited has acquired exclusive global rights to Macquarie University's innovative electrochemical silver extraction technology, promising a cleaner, more efficient way to recycle silver from solar panels while preserving valuable silicon wafers.

Wrkr Limited is raising approximately A$15 million through an institutional placement to accelerate growth amid upcoming Payday Super reforms and market opportunities.

Papyrus Australia Ltd has announced a $262,000 capital raise through a share placement and unlisted options, aiming to strengthen its working capital and research efforts.

Resonance Health reports a solid quarter with key clinical trial milestones, expansion of trial sites, and multi-year Software-as-a-Medical Device contracts, underpinning a positive cashflow outlook.